INS and fatty liver disease: Besides UDCA, several drugs including insulin resistance modifiers, antioxidants and weight loss agents have been studied and used clinically for the treatment of hepatic steatosis; however, there are concerns about the safety of these drugs and the side effects associated with long-term use10.